Close Menu

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    ‘A Roberto Clemente throw:’ Braves’ Ronald Acuña Jr. Has Incredible Web Gem

    Technetium-99m Market Size to Reach USD 6.29 Billion by 2031, Growing at a CAGR of 3.9%

    Inside the Strike on Iran’s Nuclear Program

    Facebook X (Twitter) Instagram
    Facebook X (Twitter) Instagram Pinterest VKontakte
    Sg Latest NewsSg Latest News
    • Home
    • Politics
    • Business
    • Technology
    • Entertainment
    • Health
    • Sports
    Sg Latest NewsSg Latest News
    Home»Health»Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3%
    Health

    Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3%

    AdminBy AdminNo Comments6 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Email
    Share
    Facebook Twitter LinkedIn Pinterest Email


    NEW YORK, July 18, 2025 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing significantly with the increasing prevalence of ocular diseases.

    The global preservative-free eye drops market is expected to reach US$1.67 billion in 2031 from US$1.21 billion in 2024. The market is estimated to grow at a CAGR of 4.3% from 2025 to 2031. The increasing prevalence of ocular diseases, the aging global population, surging awareness for chemical-free products, and supportive regulations and recommendations fuel market growth. However, limited availability of such products in the market and shorter shelf life hinder market growth.

    To explore the valuable insights in the Preservative Free Eye Drops Market report, you can easily download a sample PDF of the report – https://www.theinsightpartners.com/sample/TIPRE00038962

    The preservative-free eye drops market is segmented on the basis of type, application, and distribution channel. The report runs an in-depth analysis of market trends, key players, and future opportunities.

    Overview of Report Findings

    Increasing Prevalence of Ocular Diseases:

    Age-related complications such as cataracts, glaucoma, and macular degeneration are among the top causes of vision loss globally. As per the report ‘Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment’ published in 2022, age-related macular degeneration impacts over 200 million people worldwide and is expected to reach 300 million by 2040. As per the WHO 2023, in Europe, approximately 90 million people have some form of vision impairment or blindness, representing ~9% of the population. The prevalence of these complications highlights the need for efficient eye care treatment. Preservative-free eye drops provide a safer option for people suffering from chronic eye diseases, reducing the risk of preservative-related irritation and toxicity.

    Rising Aging Population:

    With age, individuals become more prone to dry eye syndrome, glaucoma, age-related macular degeneration, and cataracts. These disorders need to be treated long-term or even for a lifetime through ophthalmic solutions. But conventional preservative-containing eye drops such as those containing benzalkonium chloride (BAK), are known to induce or worsen irritation, inflammation, and injury to the ocular surface, particularly with prolonged use.

    Elderly patients are susceptible to such side effects because of thinner tear films and lower regenerative capacity of the ocular surface. Preservative-free eye drops, which provide a milder and safer option, are increasingly being favored among this population. The tendency is particularly prominent in industrialized nations with an accelerating aging population, including Japan, Germany, and the US. It is also gaining prominence in China and India. Clinicians today are inclined to prescribe preservative-free drugs for older patients with chronic diseases. With the world population aged 60 and above expected to double by the year 2050, demand for safer, better-tolerated ophthalmic products will surge, driving market growth.

    For Detailed Preservative Free Eye Drops Market Insights, Visit: https://www.theinsightpartners.com/reports/preservative-free-eye-drops-market

    Geographical Insights:

    In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR in the preservative free eye drops market during the forecast period.

    Market Segmentation

    • By type, the preservative free eye drops market is segmented into single dose and multiple dose. The single-dose segment held a larger share of the market in 2024, and it is anticipated to register the highest CAGR in the market during 2025–2031.
    • Based on application, the preservative free eye drops market has been segmented into dry eye disease (DED), eye allergy/ infection, glaucoma, retinal disorders, and other indications. The dry eye disease segment held the largest share of the market in 2024 and is expected to register a higher CAGR in the market during 2025–2031.
    • In terms of distribution channel, the preservative free eye drops market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2024. The online pharmacies segment is expected to register the highest CAGR in the market during 2025–2031.
    • The preservative free eye drops market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America.

    Stay Updated on The Latest Preservative Free Eye Drops Market Trends: https://www.theinsightpartners.com/sample/TIPRE00038962/

    Competitive Strategy and Development

    • Key Players: Major companies operating in the preservative free eye drops market are Nemera, Alcon Inc., Bausch & Lomb Incorporated, Eyekare Kilitch Ltd., Essex Bio-Technology Limited, Pillar5 Pharma Inc., iVIZIA, Allergan PLC, CorneaCare Inc.
    • Trending Topics: Dry Eye Disease (DED) Treatment, Glaucoma Therapeutics, Allergic Conjunctivitis Treatment, Contact Lens Care Products, Ophthalmic Surgical Products, Natural and Organic Eye Care Products, Pediatric Eye Care, etc.

    Global Headlines on Preservative Free Eye Drops Market

    • Lumify Preservative Free Redness-Reducing Eye Drops Launch in US
    • Alcon Announces US Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Long-Lasting Formula

    Purchase Premium Copy of Global Preservative Free Eye Drops Market Size and Growth Report (2021-2031) at:  https://www.theinsightpartners.com/buy/TIPRE00038962/

    Conclusion

    The preservative free eye drops market is growing, driven primarily by the rising prevalence of chronic ocular diseases, an aging global population, and increasing consumer awareness of the adverse effects associated with preservatives. Advances in sterile packaging technologies have made preservative-free formulations more accessible and convenient. Additionally, soaring demand for safer, natural, and more tolerable eye care products aligns with broader healthcare and lifestyle trends. However, higher production costs and limited availability in certain regions limit growth. Overall, the market’s future looks promising as healthcare providers and consumers prioritize ocular safety and comfort, making preservative-free eye drops a vital segment in the evolving ophthalmic therapeutics landscape.

    The report from The Insight Partners lists several stakeholders—including manufacturers, healthcare providers, distributors and suppliers, and regulatory bodies—along with valuable insights on how to successfully navigate this evolving market landscape and unlock new opportunities.

    Trending Related Reports:

    The Allergy Relieving Eye Drops Market Size is expected to register a CAGR of 4.2% from 2025 to 2031

    Eye Drops and Lubricants Market Size, Trends, Shares, and Forecast – 2031

    Dry Eye Disease Market Size is expected to register a CAGR of 5.6% from 2025 to 2031

    Diabetic Eye Disease Equipment Market Size, Trends, Shares, and Forecast – 2031

    Dry Eye Disease Diagnostic Devices Market Size, Trends, Shares, and Forecast – 2031

    The eye allergy treatment market size is projected to reach US$ 5.69 billion by 2030

    Retinal Surgery Devices Market Size is expected to register a CAGR of 5.9% from 2025 to 2031

    Retinal Implant Market Size is expected to register a CAGR of 8.4% from 2025 to 2031

    The Thyroid Eye Disease Treatment Market Size is expected to register a CAGR of 6.3% from 2025 to 2031

    About Us:

    The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

    Contact Us:
    If you have any queries about this report or if you would like further information, please contact us:
    Contact Person: Ankit Mathur
    E-mail: [email protected]
    Phone: +1-646-491-9876
    Press Release – https://www.theinsightpartners.com/pr/preservative-free-eye-drops-market
    For More Life Sciences Research Reports & Industry Analysis – https://www.theinsightpartners.com/reportstype/life-sciences

    Logo: https://mma.prnewswire.com/media/2520492/The_Insight_Partners_Logo.jpg

    SOURCE The Insight Partners

    Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
    Admin
    • Website

    Related Posts

    Technetium-99m Market Size to Reach USD 6.29 Billion by 2031, Growing at a CAGR of 3.9%

    Inside the Strike on Iran’s Nuclear Program

    Sleep Apnea Devices Market worth $11.6 billion by 2032 with 7.6% CAGR

    3 Democrat-led states have rolled back Medicaid access for people lacking permanent legal status

    Add A Comment
    Leave A Reply Cancel Reply

    Editors Picks

    Microsoft’s Singapore office neither confirms nor denies local layoffs following global job cuts announcement

    Google reveals “material 3 expressive” design – Research Snipers

    Trump’s fast-tracked deal for a copper mine heightens existential fight for Apache

    Top Reviews
    9.1

    Review: Mi 10 Mobile with Qualcomm Snapdragon 870 Mobile Platform

    By Admin
    8.9

    Comparison of Mobile Phone Providers: 4G Connectivity & Speed

    By Admin
    8.9

    Which LED Lights for Nail Salon Safe? Comparison of Major Brands

    By Admin
    Sg Latest News
    Facebook X (Twitter) Instagram Pinterest Vimeo YouTube
    • Get In Touch
    © 2025 SglatestNews. All rights reserved.

    Type above and press Enter to search. Press Esc to cancel.